Skip to main content
NCBI home page
Biophysical Journal logoLink to Biophysical Journal
. 1996 Jan;70(1):443–452. doi: 10.1016/S0006-3495(96)79587-5

Spectroscopic and molecular modeling studies of caffeine complexes with DNA intercalators.

R W Larsen 1, R Jasuja 1, R K Hetzler 1, P T Muraoka 1, V G Andrada 1, D M Jameson 1
PMCID: PMC1224942  PMID: 8770220

Abstract

Recent studies have demonstrated that caffeine can act as an antimutagen and inhibit the cytoxic and/or cytostatic effects of some DNA intercalating agents. It has been suggested that this inhibitory effect may be due to complexation of the DNA intercalator with caffeine. In this study we employ optical absorption, fluorescence, and molecular modeling techniques to probe specific interactions between caffeine and various DNA intercalators. Optical absorption and steady-state fluorescence data demonstrate complexation between caffeine and the planar DNA intercalator acridine orange. The association constant of this complex is determined to be 258.4 +/- 5.1 M-1. In contrast, solutions containing caffeine and the nonplanar DNA intercalator ethidium bromide show optical shifts and steady-state fluorescence spectra indicative of a weaker complex with an association constant of 84.5 +/- 3.5 M-1. Time-resolved fluorescence data indicate that complex formation between caffeine and acridine orange or ethidium bromide results in singlet-state lifetime increases consistent with the observed increase in the steady-state fluorescence yield. In addition, dynamic polarization data indicate that these complexes form with a 1:1 stoichiometry. Molecular modeling studies are also included to examine structural factors that may influence complexation.

Full text

PDF
443

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arimoto S., Fukuoka S., Itome C., Nakano H., Rai H., Hayatsu H. Binding of polycyclic planar mutagens to chlorophyllin resulting in inhibition of the mutagenic activity. Mutat Res. 1993 Jun;287(2):293–305. doi: 10.1016/0027-5107(93)90022-8. [DOI] [PubMed] [Google Scholar]
  2. Bertrand C. A., Pomper I., Hillman G., Duffy J. C., Micheli I. No relation between coffee and blood pressure. N Engl J Med. 1978 Aug 10;299(6):315–316. doi: 10.1056/NEJM197808102990625. [DOI] [PubMed] [Google Scholar]
  3. Borodina V. M., Kirianova E. E., Fedorova O. V., Zelenin A. V. Cytochemical properties of interphase chromatin condensed as a result of treatment with caffeine. Exp Cell Res. 1979 Sep;122(2):391–394. doi: 10.1016/0014-4827(79)90316-1. [DOI] [PubMed] [Google Scholar]
  4. Brunet J. E., Vargas V., Gratton E., Jameson D. M. Hydrodynamics of horseradish peroxidase revealed by global analysis of multiple fluorescence probes. Biophys J. 1994 Feb;66(2 Pt 1):446–453. doi: 10.1016/s0006-3495(94)80796-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Curatolo P. W., Robertson D. The health consequences of caffeine. Ann Intern Med. 1983 May;98(5 Pt 1):641–653. doi: 10.7326/0003-4819-98-5-641. [DOI] [PubMed] [Google Scholar]
  6. Dashwood R., Guo D. Antimutagenic potency of chlorophyllin in the Salmonella assay and its correlation with binding constants of mutagen-inhibitor complexes. Environ Mol Mutagen. 1993;22(3):164–171. doi: 10.1002/em.2850220309. [DOI] [PubMed] [Google Scholar]
  7. Dews P., Grice H. C., Neims A., Wilson J., Wurtman R. Report of Fourth International Caffeine Workshop, Athens, 1982. Food Chem Toxicol. 1984 Feb;22(2):163–169. doi: 10.1016/0278-6915(84)90098-x. [DOI] [PubMed] [Google Scholar]
  8. Gratton E., Jameson D. M., Hall R. D. Multifrequency phase and modulation fluorometry. Annu Rev Biophys Bioeng. 1984;13:105–124. doi: 10.1146/annurev.bb.13.060184.000541. [DOI] [PubMed] [Google Scholar]
  9. Hartman P. E., Shankel D. M. Antimutagens and anticarcinogens: a survey of putative interceptor molecules. Environ Mol Mutagen. 1990;15(3):145–182. doi: 10.1002/em.2850150305. [DOI] [PubMed] [Google Scholar]
  10. Kapuscinski J., Kimmel M. Thermodynamical model of mixed aggregation of intercalators with caffeine in aqueous solution. Biophys Chem. 1993 Apr;46(2):153–163. doi: 10.1016/0301-4622(93)85022-a. [DOI] [PubMed] [Google Scholar]
  11. Kimura H., Aoyama T. Decrease in sensitivity to ethidium bromide by caffeine, dimethylsulfoxide or 3-aminobenzamide due to reduced permeability. J Pharmacobiodyn. 1989 Oct;12(10):589–595. doi: 10.1248/bpb1978.12.589. [DOI] [PubMed] [Google Scholar]
  12. Kunicka J. E., Myc A., Melamed M. R., Darzynkiewicz Z. Caffeine increases sensitivity of DNA to denaturation in chromatin of L1210 cells. Cell Tissue Kinet. 1990 Jan;23(1):31–39. doi: 10.1111/j.1365-2184.1990.tb01107.x. [DOI] [PubMed] [Google Scholar]
  13. Lakowicz J. R., Cherek H., Maliwal B. P. Time-resolved fluorescence anisotropies of diphenylhexatriene and perylene in solvents and lipid bilayers obtained from multifrequency phase-modulation fluorometry. Biochemistry. 1985 Jan 15;24(2):376–383. doi: 10.1021/bi00323a021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Levin R. E. Influence of caffeine on mutations induced by nitrosoguanidine in Salmonella typhimurium tester strains. Environ Mutagen. 1982;4(6):689–694. doi: 10.1002/em.2860040608. [DOI] [PubMed] [Google Scholar]
  15. Mann J. I., Thorogood M. Letter: Coffee-drinking and myocardial infarction. Lancet. 1975 Dec 13;2(7946):1215–1215. doi: 10.1016/s0140-6736(75)92711-7. [DOI] [PubMed] [Google Scholar]
  16. O'Neill F. J. Differential effects of cytochalasin B and caffeine on control of DNA synthesis in normal and transformed cells. J Cell Physiol. 1979 Nov;101(2):201–217. doi: 10.1002/jcp.1041010203. [DOI] [PubMed] [Google Scholar]
  17. Pozniak P. C. The carcinogenicity of caffeine and coffee: a review. J Am Diet Assoc. 1985 Sep;85(9):1127–1133. [PubMed] [Google Scholar]
  18. Ross W. E., Zwelling L. A., Kohn K. W. Relationship between cytotoxicity and DNA strand breakage produced by adriamycin and other intercalating agents. Int J Radiat Oncol Biol Phys. 1979 Aug;5(8):1221–1224. doi: 10.1016/0360-3016(79)90642-4. [DOI] [PubMed] [Google Scholar]
  19. Selby C. P., Sancar A. Molecular mechanisms of DNA repair inhibition by caffeine. Proc Natl Acad Sci U S A. 1990 May;87(9):3522–3525. doi: 10.1073/pnas.87.9.3522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Tachino N., Guo D., Dashwood W. M., Yamane S., Larsen R., Dashwood R. Mechanisms of the in vitro antimutagenic action of chlorophyllin against benzo[a]pyrene: studies of enzyme inhibition, molecular complex formation and degradation of the ultimate carcinogen. Mutat Res. 1994 Jul 16;308(2):191–203. doi: 10.1016/0027-5107(94)90154-6. [DOI] [PubMed] [Google Scholar]
  21. Traganos F., Kapuscinski J., Darzynkiewicz Z. Caffeine modulates the effects of DNA-intercalating drugs in vitro: a flow cytometric and spectrophotometric analysis of caffeine interaction with novantrone, doxorubicin, ellipticine, and the doxorubicin analogue AD198. Cancer Res. 1991 Jul 15;51(14):3682–3689. [PubMed] [Google Scholar]

Articles from Biophysical Journal are provided here courtesy of The Biophysical Society

RESOURCES